Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure

Figures

• 

  Fig. 1. Study flow chart

• 

  Fig. 2. The formulas for calculating the model for end-stage liver disease (MELD) score and modified MELD scores

• 

  Fig. 3. Quantitative distribution of the model for end-stage liver disease (MELD) score and its 3 modifications (a). Pairwise Spearman correlations among MELD score and its 3 modifications (b). ***, P < 0.001

• 

  Fig. 4. Time-dependent ROC analysis (a) and areas under the curve (b) of the model for end-stage liver disease (MELD) score and its 3 modifications for all-cause mortality

• 

  Fig. 5. Time-dependent ROC analysis (a) and areas under the curve (b) of the model for end-stage liver disease (MELD) score and its 3 modifications for cardiovascular mortality